search
Back to results

ReShape Intragastric Balloon for the Treatment of Obesity (ITALYIII)

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
ReShape Duo Balloon
Sponsored by
ReShape Lifesciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring obesity, intragastric balloon

Eligibility Criteria

20 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • The patient is male or female between the ages of 20 and 60 years of age.
  • The patient presents with a Body Mass Index (BMI) 30-40 kg/m2.
  • The patient is geographically stable and willing to return to the implant center for follow-up visits.
  • The patient has been adequately informed of risks and requirements and consents to his/her participation in the post market clinical study.

Exclusion Criteria:

  • The patient presents with 20 years > Age > 60 years.
  • The patient has a progressive disease, which in the Investigator's experience produces an unacceptable increased risk to the patient, or results in a life expectancy of less than 12 months.
  • The patient is a pregnant or lactating female.
  • The patient presents with a 30 kg/m2 > BMI > 40 kg/m2.
  • The patient has had previous abdominal surgery.
  • The patient has digestive tract disorders such as active peptic ulcers, bleeding disorders, esophageal varices, Crohn's disease.
  • The patient presents with psychiatric disorders.
  • The patient is participating in concomitant research studies of investigational products that would interfere with this study.
  • The patient has inability to return for follow-up assessments.
  • The patient is an alcohol or drug abuser.

Sites / Locations

  • Casa di Cura Solatrix
  • Regional Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

ReShape Duo Balloon

Arm Description

Patients seeking weight loss with a starting BMI in the 30-40 range, received the ReShape Duo Balloon

Outcomes

Primary Outcome Measures

Total Weight Loss
Mean weight loss in kilograms compared with the baseline value through 6 months of study follow up.

Secondary Outcome Measures

Full Information

First Posted
November 25, 2009
Last Updated
September 10, 2015
Sponsor
ReShape Lifesciences
Collaborators
Regional Hospital. Viale Rodolfi 37. 36100 Vicenza. ITALY, Casa di Cura Solatrix. Via Bellini 11. 38068 Rovereto. ITALY
search

1. Study Identification

Unique Protocol Identification Number
NCT01024465
Brief Title
ReShape Intragastric Balloon for the Treatment of Obesity
Acronym
ITALYIII
Official Title
ReShape Intragastric Balloon for the Treatment of Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
September 2009 (undefined)
Primary Completion Date
May 2010 (Actual)
Study Completion Date
March 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ReShape Lifesciences
Collaborators
Regional Hospital. Viale Rodolfi 37. 36100 Vicenza. ITALY, Casa di Cura Solatrix. Via Bellini 11. 38068 Rovereto. ITALY

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
A prospective, non-randomized, open-label, multi-center study designed to implant up to twenty-six (26) CE-marked ReShape™ Balloons in twenty-six (26) patients with body mass index (BMI) 30-40 to assess the effectiveness of the device. The RIB devices will be used within their labeled indications and as per their instructions for use. Enrolled patients will be followed for seven months. The patient will be prescribed a controlled diet, exercise and counseling. One group of 26 patients will receive treatment as follows: Placement, inflate to 900 cc, remove at 180 days, follow-up 30 days post removal (endoscopic video capture of placement and removal required).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
obesity, intragastric balloon

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
26 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ReShape Duo Balloon
Arm Type
Experimental
Arm Description
Patients seeking weight loss with a starting BMI in the 30-40 range, received the ReShape Duo Balloon
Intervention Type
Device
Intervention Name(s)
ReShape Duo Balloon
Intervention Description
ReShape Duo Balloon
Primary Outcome Measure Information:
Title
Total Weight Loss
Description
Mean weight loss in kilograms compared with the baseline value through 6 months of study follow up.
Time Frame
baseline to 180 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The patient is male or female between the ages of 20 and 60 years of age. The patient presents with a Body Mass Index (BMI) 30-40 kg/m2. The patient is geographically stable and willing to return to the implant center for follow-up visits. The patient has been adequately informed of risks and requirements and consents to his/her participation in the post market clinical study. Exclusion Criteria: The patient presents with 20 years > Age > 60 years. The patient has a progressive disease, which in the Investigator's experience produces an unacceptable increased risk to the patient, or results in a life expectancy of less than 12 months. The patient is a pregnant or lactating female. The patient presents with a 30 kg/m2 > BMI > 40 kg/m2. The patient has had previous abdominal surgery. The patient has digestive tract disorders such as active peptic ulcers, bleeding disorders, esophageal varices, Crohn's disease. The patient presents with psychiatric disorders. The patient is participating in concomitant research studies of investigational products that would interfere with this study. The patient has inability to return for follow-up assessments. The patient is an alcohol or drug abuser.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mary Lou Mooney
Organizational Affiliation
ReShape Medical
Official's Role
Study Director
Facility Information:
Facility Name
Casa di Cura Solatrix
City
Rovereto
ZIP/Postal Code
38068
Country
Italy
Facility Name
Regional Hospital
City
Vicenza
ZIP/Postal Code
36100
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

ReShape Intragastric Balloon for the Treatment of Obesity

We'll reach out to this number within 24 hrs